This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Rajesh Raikar
Introduction
Rajesh Raikar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of metered dose inhalers. His work focuses on improving the delivery of medication for respiratory disorders, which is crucial for patients suffering from conditions like asthma.
Latest Patents
Rajesh Raikar holds 1 patent for his invention titled "Metered dose inhalers of fluticasone or an ester thereof." This invention relates to a metered dose inhaler that comprises a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester. The inhaler is designed with a canister fitted with a metering valve, an actuator, and a dose counter. The invention also includes a process for preparing the pharmaceutical composition and its application in treating respiratory disorders such as asthma in subjects, including humans.
Career Highlights
Rajesh Raikar is currently employed at Glenmark Pharmaceuticals Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to create innovative solutions for healthcare challenges. His contributions have been instrumental in advancing the company's product offerings in respiratory therapies.
Collaborations
Throughout his career, Rajesh has collaborated with several professionals in the field. Notable coworkers include Julianne Berry and Rajesh Ankam, who have worked alongside him on various projects aimed at enhancing pharmaceutical formulations.
Conclusion
Rajesh Raikar's innovative work in the development of metered dose inhalers exemplifies his commitment to improving patient care in respiratory health. His contributions to Glenmark Pharmaceuticals Limited and the pharmaceutical industry as a whole highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
